Gillian Watson
Trial Manager
- Proctor SJ, Wilkinson J, Jones G, Watson GC, Lucraft HH, Mainou-Fowler T, Culligan D, Galloway MJ, Wood KM, McNally RJ, James PW, Goodlad JR. Prospective evaluation of treatment outcome in 175 patients with Hodgkin lymphoma (HL) aged 60 years or over: the SHIELD study.
Blood 2012, (epub ahead of print).
- Proctor SJ, Wilkinson J, Culligan D, Galloway M, Lucraft HH, Jones G, Mcnally R, Wood KM, Mainou-Fowler T, Watson G, Goodlad JR. Comparative clinical responses of three chemotherapy schedules (VEPEMB, ABVD, CLVPP) in 175 Hodgkin Lymphoma patients over 60ys evaluated as part of the Shield (Hodgkin elderly) Study.
In: Annals of Oncology: 11th International Conference on Malignant Lymphoma. 2011, Lugano, Switzerland: Oxford University Press.
- Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K. Uncoupling proteins in human heart.
Lancet 2004, 364(9447), 1786-1788.
- Collie-Duguid ES, Johnston SJ, Powrie RH, Milano G, Etienne MC, Rochat B, Watson GC, McLeod HL. Cloning and initial characterization of the human DPYD gene promoter.
Biochemical and Biophysical Research Communications 2000, 271(1), 28-35.
